Abstract: The present invention provides a cell culture medium composition containing 150 ng/mL or more of basic fibroblast growth factor (bFGF).
| # | Name | Date |
|---|---|---|
| 1 | 202247045181.pdf | 2022-08-08 |
| 2 | 202247045181-STATEMENT OF UNDERTAKING (FORM 3) [08-08-2022(online)].pdf | 2022-08-08 |
| 3 | 202247045181-PROOF OF RIGHT [08-08-2022(online)].pdf | 2022-08-08 |
| 4 | 202247045181-PRIORITY DOCUMENTS [08-08-2022(online)].pdf | 2022-08-08 |
| 5 | 202247045181-FORM 1 [08-08-2022(online)].pdf | 2022-08-08 |
| 6 | 202247045181-DRAWINGS [08-08-2022(online)].pdf | 2022-08-08 |
| 7 | 202247045181-DECLARATION OF INVENTORSHIP (FORM 5) [08-08-2022(online)].pdf | 2022-08-08 |
| 8 | 202247045181-COMPLETE SPECIFICATION [08-08-2022(online)].pdf | 2022-08-08 |
| 9 | 202247045181-FORM-26 [02-09-2022(online)].pdf | 2022-09-02 |
| 10 | 202247045181-Correspondence_Form-1 And POA_02-12-2022.pdf | 2022-12-02 |
| 11 | 202247045181-FORM 3 [30-01-2023(online)].pdf | 2023-01-30 |
| 12 | 202247045181-FORM 18 [13-12-2023(online)].pdf | 2023-12-13 |